Form 4: LeMaitre Vascular CEO Acquires Shares Through Dividend Equivalent Rights

LeMaitre Vascular's CEO, George W. LeMaitre, acquired shares through the release of dividend equivalent rights and a tax withholding transaction.

Summary

• LeMaitre Vascular's CEO, George W. LeMaitre, acquired 9 shares of common stock on December 9, 2024, through the release of dividend equivalent rights.
• These shares were acquired on a one-for-one basis with the dividend equivalent rights.
• Additionally, 532 shares were sold at $101.12 per share to cover tax withholding obligations related to restricted stock units that vested on December 8, 2023.
• The dividend equivalent rights were associated with a restricted stock unit award granted on December 8, 2023.
• Each dividend equivalent right is equivalent to one share of the company's common stock.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and does not indicate any significant positive or negative sentiment. It is a routine transaction.

Industry Context

This filing reflects routine executive compensation practices involving stock-based awards and tax obligations, which are common in publicly traded companies.

Comparison to Industry Standards

• The use of restricted stock units and dividend equivalent rights is a standard practice for executive compensation in the medical device industry.
• The sale of shares to cover tax obligations is also a common occurrence when stock options or restricted stock units vest.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves a small number of shares.
• The transaction is part of the executive compensation plan and does not indicate any significant change in the company's operations.

Key Dates

Keywords

LeMaitre Vascular, George W. LeMaitre, dividend equivalent rights, restricted stock units, share acquisition, tax withholding